| View |
|
DR-XY48643
|
Ceftazidime (As Pentahydrate)
|
Aetaz
|
1 g
|
Powder for Injection (IM/IV)
|
-
|
Shenzhen China Resources Gosun Pharmaceuticals Co., Ltd.
|
China
|
Initial
|
09 March 2023
|
09 March 2028
|
| View |
|
DRP-13605
|
Meropenem (as trihydrate)
|
Hyertic-500
|
500 mg
|
Powder for Solution for Injection (IV)
|
-
|
Brooks Steriscience Limited
|
India
|
Initial
|
16 March 2023
|
16 March 2028
|
| View |
|
DRP-13603
|
Etoricoxib
|
None
|
120mg
|
Film-Coated Tablet
|
-
|
Getz Pharma Pvt. Ltd.
|
Pakistan
|
Initial
|
15 March 2023
|
15 March 2028
|
| View |
|
DR-XY48649
|
Sterile Water For Injection
|
None
|
50mL in 50mL, 100mL in 100mL; 500mL in 500mL; 1000mL in 1000mL
|
Solution For Injection
|
-
|
General Hospital Products Public Co., Ltd.
|
Thailand
|
Initial
|
13 March 2023
|
13 March 2028
|
| View |
|
DRP-13578
|
Moxifloxacin (as hydrochloride)
|
Maxobles
|
5 mg/mL (0.5% w/v)
|
Ophthalmic Solution :
|
-
|
Makcur Laboratories Limited
|
India
|
Initial
|
13 March 2023
|
13 March 2025
|
| View |
|
DRP-13516
|
Salbutamol (As Sulfate)
|
Prevasal
|
100 mcg/ actuation
|
Metered-Dose Inhaler
|
-
|
Jewim Pharmaceutical (Shandong) Co. Ltd.
|
China
|
Initial
|
14 March 2023
|
14 March 2028
|
| View |
|
DRP-13604
|
Losartan Potassium
|
Ulosar 100
|
100mg
|
Film-Coated Tablet
|
-
|
Globela Pharma Private Limited
|
India
|
Initial
|
15 March 2023
|
15 March 2026
|
| View |
|
DRP-13616
|
Telmisartan + Amlodipine (as besilate)
|
Telmisar AM
|
40 mg/5 mg
|
Tablet
|
-
|
Mediwin Pharmaceuticals
|
India
|
Initial
|
17 March 2023
|
17 March 2028
|
| View |
|
DR-XY48654
|
Mutivitamins + Zinc
|
Enervon Z+
|
Each Film-Coated Tablet contains:
Ascorbic Acid (Vitamin C)
(equivalent to 568.11 mg of Sodium Ascorbate) 500 mg
Thiamine Mononitrate (Vitamin B1) 50 mg
Riboflavin (Vitamin B2) 20 mg
Niacinamide (Vitamin B3) 20 mg
Calcium Pantothenate (Vitamin B5) 20 mg
Pyridoxine Hydrochloride (Vitamin B6) 5 mg
Cyanocobalamin (Vitamin B12)4 mcg
d-Alpha-Tocopheryl Acid Succinate
(Vitamin E) 11 IU
Zinc Sulfate
(equivalent to 27.5 mg Zinc Sulfate monohydrate) 10 mg
|
Film-Coated Tablet
|
-
|
UNILAB, Inc.
|
Philippines
|
Initial
|
15 March 2023
|
15 March 2028
|
| View |
|
DRP-13607
|
Lactulose
|
Lactusaph
|
3.33 g/5 mL
|
Syrup
|
-
|
Enicar Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
17 March 2023
|
17 March 2028
|
| View |
|
DR-XY48650
|
Lactated Ringer's Solution
|
None
|
600 mg/30 mg/20 mg/310 mg per 100 mL
|
Solution for
IV Infusion
|
-
|
A.N.B. Laboratories Co., Ltd.
|
Thailand
|
Initial
|
14 March 2023
|
14 March 2028
|
| View |
|
DRP-13608
|
Levocetirizine dihydrochloride
|
Levosaphzine-5
|
2.5mg/5mL
|
Syrup
|
-
|
Enicar Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
17 March 2023
|
17 March 2028
|
| View |
|
DRP-13552
|
Atenolol
|
Vasten
|
50 mg
|
Tablet
|
-
|
Healer's Lab (Unit II)
|
India
|
Initial
|
09 March 2023
|
09 March 2028
|
| View |
|
DRP-13577
|
Metronidazole
|
Nidaz
|
5 mg/mL (500 mg/100 mL)
|
Solution for Intravenous
Infusion
|
-
|
Eurolife Healthcare Pvt. Ltd.
|
India
|
Initial
|
13 March 2023
|
13 March 2028
|
| View |
|
DRP-13553
|
Bendamustine Hydrochloride
|
Xyotin
|
100 mg
|
Lyophilized Powder for Concentrate for Solution. for I.V. Infusion
|
-
|
Naprod Life Sciences Pvt. Ltd.
|
India
|
Initial (from Monitored Release)
|
09 March 2023
|
28 December 2026
|
| View |
|
DRP-13609
|
Clindamycin (as hydrochloride)
|
Clintop
|
150mg
|
Capsule
|
-
|
Fredun Pharmaceutical Limited
|
India
|
Initial
|
16 March 2023
|
16 March 2028
|
| View |
|
HRP-578
|
Povidone-Iodine
|
Povin
|
10% (1% w/v)
|
Topical Solution
|
-
|
Nagindas Hiralal Bhayani
|
India
|
Initial
|
15 March 2023
|
15 March 2028
|
| View |
|
DRP-13618
|
Pioglitazone (As Hydrochloride)
|
Pioglitasaph-15
|
15 mg
|
Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
17 March 2023
|
17 March 2028
|
| View |
|
DRP-13617
|
Pioglitazone (As Hydrochloride)
|
Pioglitasaph-30
|
30mg
|
Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
17 March 2023
|
17 March 2028
|
| View |
|
DRP-13619
|
Febuxostat
|
Febufast 120
|
120 mg
|
Film-Coated Tablet
|
-
|
MSN
Laboratories
Private
Limited (Formulations Division)
|
India
|
Initial
|
17 March 2023
|
17 March 2028
|